Effect of the pyridoindole antioxidant stobadine on sodium handling of renal Na,K-ATPase in rats with streptozotocin-induced diabetes

Acta Diabetologica

Volumn 41, Issue 4, 2004, Pages 172-178

  Vrbjar, N ^a   Strelkova S ^a   Stefek M ^b   Kyselova Z ^b   Gajdosikova A ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Diabetes; Kidney; Sodium pump

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); CARBOLINE DERIVATIVE; SODIUM; STOBADINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; ENZYME INHIBITION; INJECTION SITE; KIDNEY FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SODIUM URINE LEVEL; STREPTOZOCIN DIABETES;

ANIMALS; ANTIOXIDANTS; CARBOLINES; DIABETES MELLITUS, EXPERIMENTAL; DIET; KIDNEY; KINETICS; MALE; NA(+)-K(+)-EXCHANGING ATPASE; RATS; RATS, WISTAR; SODIUM;

EID: 12944299784     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00592-004-0162-y     Document Type: Article

References (38)

1. O'Hare JA, Ferris JB, Brady D, Twomey B, O'Sullivan D (1985) Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy. Hypertension 7[Suppl 2]:43-48
2. Weidmann P, Ferrari P (1991) Central role of sodium in hypertension in diabetic subjects. Diabetes Care 14: 220-232
3. Tsimaratos M, Coste TC, Djemli-Shipkolye A, Daniel L, Shipkolye F, Vague P, Raccah D (2001) Evidence of time-dependent changes in renal medullary Na,K-ATPase activity and expression in diabetic rats. Cell Mol Biol (Noisy-le-grand) 47:239-245
4. Baynes JW, Thorpe SR (1999) Perspectives in diabetes. Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes 48:1-9
5. Rackova L, Stefek M, Majekova M (2002) Structural aspects of antioxidant activity of substituted pyridoindoles. Redox Report 7:207-214
6. Stefek M, Gajdosik A, Tribulova N, Navarova J, Volkovova K, Weismann P, Gajdosikova A, Drimal J, Mihalova D (2002) The pyridoindole antioxidant stobadine attenuates albuminuria, enzymuria, kidney lipid peroxidation and matrix collagen crosslinking in streptozotocin-induced diabetic rats. Methods Find Exp Clin Pharmacol 24:565-571
7. Stefek M, Tribulova N, Gajdosik A, Gajdosikova A (2002) The pyridoindole antioxidant stobadine attenuates histochemical changes in kidney of streptozotocin-induced diabetic rats. Acta Histochem 104:413-417
8. Jorgensen PL (1974) Purification and characterization of (Na+,K+)-ATPase: III. Purification from the outer medulla of mammalian kidney after selective removal of membrane components by sodium dodecylsulphate. Biochim Biophys Acta 356:36-52
9. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
10. Taussky HH, Shorr EE (1953) A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem 202:675-685
11. Davel APC, Rossoni LV, Vassallo DV (2000) Effects of ouabain on the pressor response to phenylephrine and on the sodium pump activity in diabetic rats. Eur J Pharmacol 406:419-427
12. Michea L, Irribarra V, Goecke IA, Marusic ET (2001) Reduced Na-K pump but increased Na-K-2Cl cotransporter in aorta of streptozotocin-induced diabetic rat. Am J Physiol Heart Circ Physiol 280:H851-H858
13. Tsimaratos M, Coste TC, Djemli-Shipkolye A, Vague P, Pieroni G, Raccah D (2001) γ-Linolenic acid restores renal medullary thick ascending limb Na+,K+-ATPase activity in diabetic rats. J Nutr 131:3160-3165
14. Unlucerci Y, Kocak H, Seferoglu G, Bekpinar S (2001) The effect of aminoguanidine on diabetes-induced inactivation of kidney Na+,K+-ATPase in rats. Pharmacol Res 44:95-98
15. Stefek M, Sotnikova R, Okruhlicova L, Volkovova K, Kucharska J, Gajdosik A, Gajdosikova A, Mihalova D, Hozova R, Tribulova N, Gvozdjakova A (2000) Effect of dietary supplementation with the pyridoindole antioxidant stobadine on antioxidant state and ultrastructure of diabetic rat myocardium. Acta Diabetol 37:111-117
16. Sotnikova R, Stefek M, Okruhlicova L, Navarova J, Bauer V, Gajdosik A Gajdosikova A (2001) Dietary supplementation of the pyridoindole antioxidant stobadine reduces vascular impairment in streptozotocin diabetic rats. Methods Find Exp Clin Pharmacol 23:121-129
17. Ziegelhoffer A, Ravingerova T, Styk J, Sebokova J, Waczulikova I, Breier A, Dzurba A, Volkovova K, Carsky J, Turecky L (1997) Mechanisms that may be involved in calcium tolerance of the diabetic heart. Mol Cell Biochem 176:191-198
18. Ziegelhoffer A, Ravingerova T, Styk J, Tribulova N, Volkovova K, Sebokova J, Breier A (1996) Diabetic cardiomyopathy in rats: biochemical mechanisms of increased tolerance to calcium overload. Diabetes Res Clin Pract Suppl 31:S93-S103
19. Ver A, Szanto I, Banyasz T, Csermely P, Vegh E, Somogyi J (1997) Changes in the expression of Na+/K+-ATPases isoenzymes in the left ventricle of diabetic rat hearts: effect on insulin treatment. Diabetologia 40:1255-1256
20. Kato K, Lukas A, Chapman DC, Rupp H, Dhalla NS (2002) Differential effects of etomoxir treatment on cardiac Na+-K+ ATPase subunits in diabetic rats. Mol Cell Biochem 232:57-62
21. Cameron NE, Cotter MA, Jack AM, Basso MD, Hohman TC (1999) Protein kinase C effects on nerve function, perfusion, Na(+), K(+)-ATPase activity and glutathione content in diabetic rats. Diabetologia 42:1120-1130
22. Bensaoula T, Ottlecz A (2001) Biochemical and ultrastructural studies in the neural retina and retinal pigment epithelium of STZ-diabetic rats: effect of captopril. J Ocul Pharmacol Ther 17:573-586
23. Lal MA, Korner A, Matsuo Y, Zelenin S, Cheng SXJ, Jaremko G, DiBona GF, Eklof AC, Aperia A (2000) Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats. Diabetes 49:1381-1389
24. Chen S, Yuan C, Clough D, Haddy FJ, Pamnani MB (1993) Role of digitalis-like substance in experimental insulin-dependent diabetes mellitus hypertension. J Cardiovasc Pharmacol 22[Suppl 2]:S20-S21
25. Chen S, Yuan C, Clough D, Schooley J, Haddy FJ, Pamnani MB (1993) Role of digitalis-like substance in the hypertension of streptozotocin-induced diabetes in reduced renal mass rats. Am J Hypertens 6:397-406
26. Pamnani MB, Chen X, Haddy FJ, Schooley JF, Mo Z (2000) Mechanism of antihypertensive effect of dietary potassium in experimental volume expanded hypertension in rats. Clin Exp Hypertens 22:555-569
27. Gupta S, Phipps K, Ruderman NB (1996) Differential stimulation of Na+pump activity by insulin and nitric oxide in rabbit aorta. Am J Physiol 270(4 Pt 2):H1287-H1293
28. Tack CJ, Lutterman JA, Vervoort G, Thein T, Smits P (1996) Activation of the sodium-potassium pump contribute to insulin-induced vasodilation in humans. Hypertension 28:426-432
29. Ohtomo Y, Bergman T, Johansson BE, Jornvall H, Wahren J (1998) Differential effects of proinsulin C-peptide fragments on Na+,K+-ATPase activity of renal tubule segments. Diabetologia 41:287-291
30. Traverse N, Menini S, Cosso E, Odetti P, Albano E, Pronzato MA, Marinari UM (1998) Immunological evidence for increased oxidative stress in diabetic rats. Diabetologia 41:265-270
31. Tugrul Y, Bekpinar S (1997) Effect of chronic ethanol treatment on oxidant-induced changes in Na+,K+-ATPase and some related parameters in rat brain. Res Commun Alcohol Subst Abuse 18:47-56
32. Ravingerova T, Dzurba A, Vrbjar N, Tribulova N, Ziegelhoeffer A, Slezak J (1994) Free oxygen radicals-induced impairment of hearth function: the role of Na,K-ATPase. Pharmacol (Life Sci Adv) 13:133-140
33. Thomas CE, Reed DJ (1990) Radical-induced inactivation of kidney Na+,K+-ATPase: sensitivity membrane lipid peroxidation and the protective effect of vitamin E. Arch Biochem Biophys 281:96-105
34. Horakova L, Stole S (1998) Antioxidant and pharmacodynamic effects of pyridoindole stobadine. Gen Pharmacol 30:627-628
35. Gajdosik A, Gajdosikova A, Stefek M, Navarova J Hozova R (1999) Streptozotocin-induced experimental diabetes in male Wistar rats. Gen Physiol Biophys 18:54-62
36. Gajdosik A, Ujhazy E, Gajdosikova A, Tomaskova A, Liska J, Vargova T, Balonova T (1993) A chronic 180 day toxicity of stobadine (DP1031) in rats. Cesk Fysiol 42:146
37. Gajdosikova A, Ujhazy E, Gajdosik A, Chalupa I, Blasko M, Tomaskova A, Liska J, Dubovicky M, Bauer V (1995) Chronic toxicity and micronucleous assay of the new cardioprotective agent stobadine in rats. Arzneim-Forsch Drug Res 45:531-536
38. Kagan VE, Tsuchiya M, Serbinova E, Packer L, Sies H (1993) Interaction of the pyridoindole stobadine with peroxyl, superoxide and chromanoxyl radicals. Biochem Pharmacol 45:393-400